Accessibility Menu
 
Organon & Co. logo

Organon & Co.

(NYSE) OGN

Current Price$13.26
Market Cap$3.47B
Since IPO (2021)-51%
5 YearN/A
1 Year+2%
1 Month+134%

Organon & Co. Financials at a Glance

Market Cap

$3.47B

Revenue (TTM)

$6.22B

Net Income (TTM)

$187.00M

EPS (TTM)

$0.72

P/E Ratio

18.62

Dividend

$0.08

Beta (Volatility)

0.91 (Low)

Price

$13.26

Volume

462,928

Open

$13.32

Previous Close

$13.26

Daily Range

$13.25 - $13.38

52-Week Range

$5.69 - $13.39

About Organon & Co.

Industry

Pharmaceuticals

Employees

10,000

CEO

Joseph T. Morrissey, Jr., MBA

Headquarters

Jersey City, NJ 07302, US

OGN Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

20%

Net Income Margin

3%

Return on Equity

31%

Return on Capital

12%

Return on Assets

1%

Earnings Yield

5.37%

Dividend Yield

0.60%

Payout Ratio

47.06%

Stock Overview

Market Cap

$3.47B

Shares Outstanding

260.32M

Volume

462.93K

Avg. Volume

8.61M

Financials (TTM)

Gross Profit

$3.36B

Operating Income

$1.28B

EBITDA

$1.28B

Operating Cash Flow

$700.00M

Capital Expenditure

$162.00M

Free Cash Flow

$538.00M

Cash & ST Invst.

$574.00M

Total Debt

$8.80B

Organon & Co. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.51B

-5.3%

Gross Profit

$759.00M

-15.3%

Gross Margin

50.36%

N/A

Market Cap

$3.47B

N/A

Market Cap/Employee

$347.26K

N/A

Employees

10,000

N/A

Net Income

$205.00M

-288.1%

EBITDA

$65.00M

-80.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$8.23B

+1.6%

Accounts Receivable

$1.43B

-3.9%

Inventory

$0.00

-100.0%

Long Term Debt

$8.76B

-2.4%

Short Term Debt

$56.00M

-12.5%

Return on Assets

1.45%

N/A

Return on Invested Capital

11.87%

N/A

Free Cash Flow

$96.00M

-62.8%

Operating Cash Flow

$141.00M

-63.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRDNGuardian Pharmacy Services, Inc.
$37.10-1.25%
PAHCPhibro Animal Health Corporation
$53.18+1.30%
AVDLAvadel Pharmaceuticals plc
$21.64+0.00%
AUPHAurinia Pharmaceuticals Inc.
$15.38+0.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$94.48-0.00%
NOKNokia
$12.91+0.04%
SOFISoFi Technologies
$16.10+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%

Questions About OGN

What is the current price of Organon & Co.?

Organon & Co. is trading at $13.26 per share.

What is the 52-week range for Organon & Co.?

Over the past 52 weeks, Organon & Co. has traded between $5.69 and $13.39.

How much debt does Organon & Co. have?

As of the most recent reporting period, Organon & Co. reported total debt of $8.80B.

How much cash does Organon & Co. have on hand?

Organon & Co. reported $574.00M in cash and cash equivalents in its most recent financial results.

What is Organon & Co.’s dividend yield?

Organon & Co. currently has a dividend yield of 0.60%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.